Offer - Urjas Oil for just ₹ 1 X
Milibact 500 Mg/250 Mg Injection is a commercial drug that is prescribed in the form of Injection. Milibact 500 Mg/250 Mg Injection also has some secondary and off-label uses. These are listed below.
The correct dosage of Milibact 500 Mg/250 Mg Injection depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Milibact 500 Mg/250 Mg Injection include Diarrhoea, Rash, Allergic reaction. Besides the aforementioned side effects, there are other adverse effects of Milibact 500 Mg/250 Mg Injection as well, which are listed below. Normally, these side effects of Milibact 500 Mg/250 Mg Injection are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Milibact 500 Mg/250 Mg Injection's effect during pregnancy is Safe and Mild while nursing. In addition, Milibact 500 Mg/250 Mg Injection's effects on the liver, heart and kidney are discussed below in the Milibact 500 Mg/250 Mg Injection related warnings section.
Milibact 500 Mg/250 Mg Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Allergy are examples of such conditions.
Drug reaction of Milibact 500 Mg/250 Mg Injection with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Milibact 500 Mg/250 Mg Injection is not safe while driving, and is is not addictive in nature.
Milibact 500 Mg/250 Mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Milibact 500 Mg/250 Mg Injection safe for pregnant women?
There are no side effects of Milibact in pregnant women.
Is the use of Milibact 500 Mg/250 Mg Injection safe during breastfeeding?
Milibact has been seen to have minimal side effects on breastfeeding women.
What is the effect of Milibact 500 Mg/250 Mg Injection on the Kidneys?
Information about safety of Milibact for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of Milibact 500 Mg/250 Mg Injection on the Liver?
Milibact can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Milibact 500 Mg/250 Mg Injection on the Heart?
In the absence of any scientific study on the side effects of Milibact on the heart, information on safety of Milibact for the heart is unavailable.
If you are suffering from any of the following diseases, you should not take Milibact 500 Mg/250 Mg Injection unless your doctor advises you to do so -
Is this Milibact 500 Mg/250 Mg Injection habit forming or addictive?
No, you will not get addicted to Milibact 500 Mg/250 Mg Injection.
Is it safe to drive or operate heavy machinery when consuming?
After taking Milibact 500 Mg/250 Mg Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Milibact 500 Mg/250 Mg Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Milibact 500 Mg/250 Mg Injection is not used to treat mental disorders.
Interaction between Food and Milibact 500 Mg/250 Mg Injection
Taking Milibact 500 Mg/250 Mg Injection with food does not harm your health.
Interaction between Alcohol and Milibact 500 Mg/250 Mg Injection
Information about the interaction of Milibact 500 Mg/250 Mg Injection and alcohol is not currently available because this topic has not been researched yet.
Milibact is a brand name for ceftriaxone. It is a prescription drug that belongs to the class of medication called cephalosporins. It is a broad spectrum antibiotic, used for treating bacterial infections, such as bronchitis, gonorrhea, respiratory, ear, throat, and urinary tract infection.
Yes, Milibact is safe to use, if taken prescribed quantity for the prescribed duration as directed by a doctor. However, few known side effects have been observed such as stomach upset, nausea. vomiting, and bleeding. If you are experiencing any of the above-mentioned side effects inform your doctor immediately.
Yes, Milibact can be taken for cough, if it is associated with infection caused by bacteria. However, if cough gets severe and does not subside after taking this drug. Do consult a doctor for the right treatment.
Yes, you can use Milibact to treat pneumonia. It effectively relieves pneumonia, especially in children. Treatment can vary from patient to patient, so you must consult your doctor before consuming this medicine for pneumonia.
Occasionally Milibact can cause a drug to induce hemolytic anemia (abnormal Red blood cell breakdown). However, if your blood reports are showing abnormal hemolytic anemia after taking this drug please discuss with your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftriaxone
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727-728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; UNASYN® (ampicillin sodium/sulbactam sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 725
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 160-162